2016 ESC/EAS guidelines for the management of dyslipidaemias-risk prediction and treatments targets
EAS Academy. Wiklund O. 10/12/18; 233810 Disclosure(s): honoraria for lectures from AMGEN and Sanofi
Prof. Olov Wiklund
Prof. Olov Wiklund

Access to Premium Content is a benefit of Individual EAS membership. Apply for membership

Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android

For any questions contact us at office@eas-society.org

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies